44 results
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
6 May 24
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
4:30pm
million.
Upcoming Events
2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31-June 4, 2024
oAbstract #10036 titled “Type II
8-K
DAWN
Day One Biopharmaceuticals Inc
24 Apr 24
Regulation FD Disclosure
8:01am
Arm 1 had fully accrued. Details of this trial were presented in November 2023 at the Society for Neuro-Oncology meeting through two oral plenary
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
24 Apr 24
Regulation FD Disclosure
8:01am
fully accrued. Details of this trial were presented in November 2023 at the Society for Neuro-Oncology meeting through two oral plenary presentations
8-K
EX-99.1
i43p1cisgijj
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
8-K
3up1wfbkx q5s0lr
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
8-K
EX-99.2
eyg 65fjhjznw
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
8-K
EX-99.1
m2izht0m4 bdqy1xn1
6 Nov 23
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.1
988iq 69ganp
7 Aug 23
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.1
yo5galj uai87522
12 Jun 23
Regulation FD Disclosure
8:07am
8-K
EX-99.1
u9qby4b0xx4wya4o8l
5 Jun 23
Regulation FD Disclosure
6:08am
8-K
qwjbyqsa7nwexdr9kn
5 Jun 23
Regulation FD Disclosure
6:08am
8-K
EX-99.2
w9b9szcv
5 Jun 23
Regulation FD Disclosure
6:08am
8-K
EX-99.2
9v00nsgm79xs147p8
1 May 23
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
9:01am
8-K
EX-99.1
5mkfttv 73
1 May 23
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
9:01am
8-K
EX-99.1
qxi 1ftq73lgw
20 Apr 23
Regulation FD Disclosure
6:08am